Methicillin-resistant Staphylococcus aureus, Samoa, 2007-2008

Emerg Infect Dis. 2011 Jun;17(6):1023-9. doi: 10.3201/eid/1706.101083.

Abstract

Little is known about the epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in most Pacific Island nations. Relatively high rates of MRSA have been reported in Polynesian people living outside the Pacific Islands. To determine the prevalence and characteristics of MRSA, we assessed wound swabs from 399 persons with skin and soft tissue infection living in Samoa. MRSA was isolated from 9% of study participants; 34 of the 196 S. aureus isolates were MRSA. Five MRSA genotypes were identified; the 3 most common were USA300, the Queensland clone, and a sequence type 1 MRSA strain that shares <85% homology with the sequence type 1 MRSA strain common in the region (WA MRSA-1). The Southwest Pacific MRSA clone was identified but accounted for only 12% of MRSA isolates. The high prevalence of MRSA in Samoa provides impetus for initiatives to improve antimicrobial drug resistance surveillance, infection control, and antimicrobial drug use in Pacific Island nations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Humans
  • Infection Control
  • Leukocidins / genetics
  • Methicillin-Resistant Staphylococcus aureus / drug effects
  • Methicillin-Resistant Staphylococcus aureus / genetics
  • Methicillin-Resistant Staphylococcus aureus / physiology*
  • Microbial Sensitivity Tests
  • Prevalence
  • Samoa / epidemiology
  • Soft Tissue Infections / epidemiology*
  • Soft Tissue Infections / microbiology*
  • Staphylococcal Skin Infections / epidemiology*
  • Staphylococcal Skin Infections / microbiology*

Substances

  • Anti-Bacterial Agents
  • Leukocidins